This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in counteracting key pathological mechanisms associated with Parkinson's disease ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

TFE3 overexpression attenuates α-Syn toxicity in a mouse model of Parkinson's disease. TFE3 overexpression rescues autophagy defects of dop ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

The new research reveals how a protein in brain cells may drive Parkinson's onset—and offers a possible explanation for why Parkinson's is much more common in men.

New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease considered rare elsewhere.

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is an urgent need for effective and targeted therapies that can improve ...

A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

The battle against Parkinson's disease, the second most common ... As a result, further in-depth research into the disease's pathophysiology and targeted treatments is crucial, according to ...